You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sunitinib Malate

Showing 1 - 25 of 551
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastrointestinal Stromal Tumors, Renal Cell Carcinoma, Pancreatic Neuroendocrine Tumor Trial in Changchun (Sunitinib malate

Completed
  • Gastrointestinal Stromal Tumors
  • +2 more
  • Sunitinib malate capsules generic product
  • Sunitinib malate capsules reference product
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Apr 6, 2023

Colorectal Cancer, Metastatic Cancer Trial in Boulogne Billancourt (FOLFIRI regimen, fluorouracil, irinotecan HCl)

Withdrawn
  • Colorectal Cancer
  • Metastatic Cancer
  • FOLFIRI regimen
  • +7 more
  • Boulogne Billancourt, France
    Hopital Ambroise Pare
Aug 26, 2022

Thymic Carcinoma Trial in Columbus (other, biological, drug)

Recruiting
  • Thymic Carcinoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 27, 2022

Metastatic Pancreatic Neuroendocrine Tumor, Pancreatic Tumor, Stage III Pancreatic Neuroendocrine Tumor AJCC v8 Trial

Not yet recruiting
  • Metastatic Pancreatic Neuroendocrine Tumor
  • +4 more
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Jan 14, 2023

Renal Cell Carcinoma Trial in Houston (Sunitinib, Nephrectomy)

Active, not recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
  • +1 more
Oct 11, 2022

Non-Clear Cell Renal Cell Carcinoma Trial in Duarte (XL092, Nivolumab, Sunitinib Malate)

Recruiting
  • Non-Clear Cell Renal Cell Carcinoma
  • Duarte, California
    Exelixis Clinical Site #1
Jan 13, 2023

Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 6, 2022

Renal Cell Carcinoma (RCC) Trial in Heidelberg (Chimeric mAb cG250, Sunitinib malate)

Terminated
Has Results
  • Renal Cell Carcinoma (RCC)
  • Chimeric monoclonal antibody cG250
  • Sunitinib malate
  • Heidelberg, Victoria, Australia
    Austin Health (Ludwig Institute Oncology Unit)
Oct 3, 2022

Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)

Recruiting
  • Neoplasms
  • +12 more
  • Nanjing, Jiangsu, China
    Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
Oct 28, 2023

Diabetic Macular Edema, Retina Vein Occlusion Trial in United States (GB-102)

Completed
Has Results
  • Diabetic Macular Edema
  • Retina Vein Occlusion
  • Phoenix, Arizona
  • +5 more
Nov 18, 2021

Liver Cancer Trial in France (sunitinib malate, Placebo, transarterial chemoembolization)

Completed
Has Results
  • Liver Cancer
  • sunitinib malate
  • +2 more
  • Amiens, France
  • +30 more
Mar 17, 2022

Paraganglioma, Pheochromocytoma Trial in Canada, Netherlands (Sunitinib)

Active, not recruiting
  • Paraganglioma
  • Pheochromocytoma
  • Calgary, Alberta, Canada
  • +3 more
Nov 29, 2021

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Buffalo, New York
  • +1 more
Aug 11, 2022

Neovascular Age-Related Macular Degeneration Trial in United States (Drug: GB-102, Aflibercept)

Completed
Has Results
  • Neovascular Age-Related Macular Degeneration
  • Gilbert, Arizona
  • +32 more
Jan 10, 2022

Kidney Cancer Trial in New Brunswick (therapeutic allogeneic lymphocytes, sunitinib malate)

Terminated
Has Results
  • Kidney Cancer
  • therapeutic allogeneic lymphocytes
  • sunitinib malate
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Apr 23, 2021

Kidney Cancer Trial in Boston, Houston, Salt Lake City (Everolimus, Sunitinib)

Terminated
Has Results
  • Kidney Cancer
  • Boston, Massachusetts
  • +3 more
Apr 26, 2021

Metastatic Melanoma Trial in Los Angeles (sunitinib malate, temozolomide)

Completed
  • Metastatic Melanoma
  • Los Angeles, California
    University of California Los Angeles (UCLA)
Jul 30, 2020

Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Pazopanib,

Completed
Has Results
  • Renal Cell Carcinoma
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Nivolumab
  • +3 more
  • Duarte, California
  • +13 more
Nov 30, 2021

Colorectal Cancer, Metastasis Trial in Nijmegen (Sunitinib Malate, TAS 102)

Recruiting
  • Colorectal Cancer
  • Metastasis
  • Sunitinib Malate
  • TAS 102
  • Nijmegen, Netherlands
    Radboud UMC
Nov 11, 2020

Breast Cancer Trial in Vancouver, Toronto (drug, other, procedure)

Completed
  • Breast Cancer
  • sunitinib malate
  • +5 more
  • Vancouver, British Columbia, Canada
  • +1 more
Sep 16, 2020

Kidney Cancer Trial in France (sunitinib malate)

Completed
  • Kidney Cancer
  • sunitinib malate
  • Angers, France
  • +21 more
Feb 18, 2021

Kidney Cancer Trial in United States (Gemcitabine, Sunitinib)

Completed
Has Results
  • Kidney Cancer
  • Birmingham, Alabama
  • +98 more
Dec 29, 2021

Advanced Cancer Trial in Houston (Bevacizumab, Sorafenib, Erlotinib)

Completed
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 27, 2020

Advanced Renal Cell Carcinoma Trial (Sunitinib, Trebananib)

Completed
Has Results
  • Advanced Renal Cell Carcinoma
  • (no location specified)
Jun 10, 2020

Locally Advanced Papillary Renal Cell Carcinoma, Metastatic Papillary Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7

Active, not recruiting
Has Results
  • Locally Advanced Papillary Renal Cell Carcinoma
  • +6 more
  • Cabozantinib S-malate
  • +3 more
  • Anchorage, Alaska
  • +596 more
Aug 2, 2022